In the preface to Frankenstein, Mary Shelley described her reflections following conversations with other intellectuals considering 19th century science: “Perhaps a corpse would be re-animated; galvanism had given token of such things,” she wrote. “Perhaps the component parts of a creature might be manufactured, brought together, and endued with vital warmth.” Despite fear or superstition about […]
In mid-May, Cameron Health Inc. struck media gold when the New York Times and the New England Journal of Medicine both gave prominent coverage to the company's efforts to develop the medical device industry's first subcutaneous implantable cardioverter defibrillator (ICD). Not bad for a relatively unknown startup in San Clemente, California. But a week earlier, Cameron struck managerial gold when it hired Warren Watson.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company, which is developing a way to grow transplant organs in labs, has no offices or Web site yet, but it's a safe bet that Miromatrix will remain in Minnesota.